A Post-Marketing Surveillance Study of Formoterol (Foradil): Its Use in General Practice in England

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.3, 2002-01, pp. : 213-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Real-Life Treatment of Acute Exacerbations of Chronic Bronchitis with Moxifloxacin or Macrolides: A Comparative Post-Marketing Surveillance Study in General Practice

By Schaberg T.

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 733-744

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in Patients with Respiratory Tract Infections Treated in General Practice: Results of a Post-Marketing Surveillance Study

By Chen Weiqiang Wu Changgui Li Zhikui Bai Changqing

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 501-509

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in Patients with Sinusitis Treated in General Practice: Results of a Post-Marketing Surveillance Study

By W. Elies

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 431-439

Adis International

Access to resources Recommend Favorite

Once-Daily Moxifloxacin Therapy for Community-Acquired Pneumonia in General Practice: Evidence from a Post-Marketing Surveillance Study of 1467 Patients

By H. Koch

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 441-448

Adis International

Access to resources Recommend Favorite

Cardiovascular Safety and Overall Tolerability of Solifenacin in Routine Clinical Use: A 12-Week, Open-Label, Post-Marketing Surveillance Study

By Michel Martin C.

Drug Safety, Vol. 31, Iss. 6, 2008-01 ,pp. : 505-514

Adis International

Access to resources Recommend Favorite